NSN 6505-01-688-2270, 6505016882270
REMDESIVIR INJECTION

Federal Supply Classification: FSC 6505 - Drugs and Biologicals
National Item Identification Number: NIIN 016882270
Codification Country: United States
Item Name Code: INC 77777
Criticality: (X) This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
Hazardous Material Indicator Code: (P) There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product.

Availability: Request Qualified Suppliers: Currently qualifying suppliers

Manufacture or supply this part?
Join our growing community of certified suppliers.

Let Us Know

CALL ABOUT NSN 6505-01-688-2270

Our client representatives are standing by to help fulfill your request.

+1-321-773-5710

REQUEST QUOTE for 6505-01-688-2270

Have a list that needs to be quoted? Upload it here.

Upload a List

DLMS^® Summary

National Stock Number 6505-01-688-2270

National Stock Number (NSN) 6505-01-688-2270, or NIIN 016882270, (remdesivir injection) was assigned May 8, 2020 in the Federal Logistics Information System (FLIS). This NSN does not replace any other NSNs.

There are 5 manufacturer part numbers associated with this NSN. None of the associated part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by one supplier. Today, one supplier is listed as an Active supplier for this NSN. Of the active suppliers, only one supplier is deemed design controlled or valid supply parts.

This part number has not been procured by the US Government in over 5 years.

Based on a planned procurement review by the Primary Inventory Control Activity (PICA) on May 09, 2020, this NSN's acquisition method was noted as: Acquire directly from the actual manufacturer, whether or not the prime contractor is the actual manufacturer. This part is a commercial/non-developmental/off-the-shelf-item. Valid AMCs: 1, 2, 3, 4 and 5.

This NSN is assigned to Item Name Code (INC) 77777. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product. NSN 6505016882270 does not contain precious metals.

This information was last updated on Aug 01, 2025.

Technical Characteristics

SPECIAL FEATURES: (FEAT) LYOPHILIZED POWDER REMDESIVIR FOR INJECTION, 100 MG, VIALS STORE BELOW 30 C (BELOW 86 F) UNTIL REQUIRED FOR USE. IS A BROAD SPECTRUM ANTIVIRAL MEDICATION INDICATED FOR THE TREATMENT COVID-19. MECHANISM OF ACTION: INTERFERENCE WITH VIRAL RNA-DEPENDENT RNA POLYMERASE CAUSING PREMATURE TERMINATION OF VIRAL RNA TRANSCRIPTION. THE LYOPHILIZED FORMULATION NEEDS TO BE RECONSTITUTED AND THEN DILUTED INTO NORMAL SALINE IV INFUSION FLUIDS PRIOR TO USE. PACKAGED AS 5MG/ML. INTENDED FOR INTRAVENOUS ADMINISTRATION. 100MG/20ML; FOR CLINICAL TRIAL USE ONLY.
SPECIAL FEATURES: (FEAT) 100 MG/20 ML (5 MG/ML) REMDESIVIR SINGLE-DOSE VIAL CONTAINING STERILE, PRESERVATIVE-FREE, COLORLESS TO YELLOW AQUEOUS-BASED SOLUTION. REQUIRES DILUTION PRIOR TO ADMINISTRATION BY INTRAVENOUS INFUSION. STORE BELOW 30 C(BELOW 86 F) UNTIL REQUIRED FOR USE. IS A BROAD SPECTRUM ANTIVIRAL MEDICATION INDICATED FOR THE TREATMENT OF COVID-19. MECHANISM OF ACTION: INTERFERENCE WITH VIRAL RNA-DEPENDENT RNA POLYMERASE CAUSING PREMATURE TERMINATION OF VIRAL RNA TRANSCRIPTION. FOR USE UNDER EMERGENCY USE AUTHORIZATION.
PART NAME ASSIGNED BY CONTROLLING AGENCY: (CXCY) REMDESIVIR INJECTION, ANTIVIRAL IV TREATMENT FOR COVID-19, 5MG/ML